At the end of the 90s, the association of RET gene mutations with the occurrence of medullary thyroid carcinoma (MTC) and Multiple endocrine neoplasia type 2A (MEN 2A) was described[1,2]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.